Skip to main content
Equibles

Verition Fund Management LLC

Position in ADCT — ADC Therapeutics SA

CIK 1454027 GREENWICH, CT
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$43,153
+$11,658 QoQ
Shares Held
40,330
+175.3% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 113 holders
Holding Since
Mar 2023
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. ADCT ranks #12 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 40,988 $6,908,117
2 ELAN
Elanco Animal Health Inc
 250,000 $6,152,500
3 TRLV
Trulieve Cannabis Corp.
 500,000 $4,915,000
4 LQDA
Liquidia Corp
 45,233 $3,606,427
5 HIMS
Hims & Hers Health, Inc.
 97,363 $3,375,575
6 UTHR
UNITED THERAPEUTICS Corp
 3,675 $1,991,225
7 LNTH
Lantheus Holdings, Inc.
 15,000 $1,664,100
8 KNSA
Kiniksa Pharmaceuticals International, plc
 7,500 $479,625

All Filings in ADCT

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,153 40,330
2023-06-30 $31,495 14,649
2023-03-31 $21,919 11,241